Abstract
The sensitivity to fluconazole, serotype and adherence to buccal epithelial cells of 46Candida albicans isolates was studied in vitro. Strains were isolated from 18 HIV-positive patients with variable CD4+ lymphocyte counts who were receiving long-term fluconazole therapy. Results showed that sensitivity to fluconazole correlated with serotype. Of the sensitive isolates 81.5 % were serotype A and 18.5 % serotype B, whereas of the resistant isolates 37.5 % were serotype A and 62.5 % serotype B. Sensitivity to fluconazole also correlated with adherence capacity, resistant isolates showing slightly less adherence to buccal epithelial cells than sensitive isolates. Weakly adherent isolates represented 87 % of resistant isolates and only 63 % of sensitive isolates. Resistant strains were isolated in highly immunocompromised patients. All strains isolated in patients with CD4+ lymphocyte counts above 200 lymphocytes/µl were sensitive, whereas intermediate and resistant strains were isolated in patients with counts below 200 lymphocytes/µl. Statistical analyses showed no correlation between adherence of isolates to buccal epithelial cells and CD4+ lymphocyte counts.
Similar content being viewed by others
References
Stein DS, Korvick JA, Vermund SH: CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. Journal of Infectious Diseases 1992, 165: 352–363.
Bart-Delabesse E, Boiron P, Carlotti A, Dupont B:Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. Journal of Clinical Microbiology 1993, 31: 2933–2937.
Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RHR: Development of resistance inCanadida isolates from patients receiving prolonged antifungal therapy. Antimicrobial Agents and Chemotherapy 1991, 35: 2302–2305.
Dupont B, Graybill JR, Amstrong D, Laroche R, Touzé JE, Wheat LJ: Fungal infections in AIDS patients. Journal of Medical and Veterinary Mycology 1992, 30: 19–28.
Smith D, Boag F, Midley J, Gazzard B: Fluconazole resistantCandida in AIDS. Journal of Infection 1991, 23: 345–346.
Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR: Correlation of in vitro fluconazole resistance ofCandida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 1993, 37: 2449–2453.
Reynes J, Mallié M, André D, Janbon F, Bastide JM: Traitement et prophylaxie secondaire par fluconazole des candidoses oropharyngées des sujets VIH+. Analyse des échecs. Pathologie Biologie 1992, 40: 513–517.
Van der Walt JP, Yarrow D: Methods for isolation, maintenance, classification and identification of yeasts. In: Kregervan Rij, NJW (ed): The yeasts. A taxonomic study. Elsevier, Amsterdam, 1984, p. 45–104.
Cox F: Adherence ofCandida Albicans to buccal epithelial cells in children and adults. Journal of Laboratory and Clinical Medicine 1983, 102: 960.
Ghannoum MA, Burns GR, Abu Elteen K, Radwan SS: Experimental evidence for the role of lipids in adherence ofCandida spp. to human buccal epithelial cells. Infection and Immunity 1986, 54: 189.
Reynes J, Mallié M, Ravisse P, Bastide JM: Activity of fluconazole againstCandida albicans isolates from HIV+ patients in a digestive candidosis turkey model. Journal of Medical and Veterinary Mycology 1992, 30: 363–367.
Kennedy MJ, Johnson AM, Volz PA, Neely AN, Yancey RJ: Virulence and adhesive properties of serotype A and B ofCandida albicans isolated from paediatric burn patients. Journal of Medical Microbiology 1992, 36: 428–436.
Sobel JD, Myers PG, Kaye D, Levison ME: Adherence ofCandida albicans to human vaginal and buccal epithelial cells. Journal of Infectious Diseases 1981, 143: 76–82.
Ghannoum MA:Candida albicans antifungal resistant strains: studies on adherence and other pathogenicity related characteristics. Mycoses 1992, 35: 131–139.
Ghannoum MA, Radwan SS: The adherence process. In: Ghannoum MA, Radwan SS (ed):Candida adherence to epithelial cells. CRC Press, Boca Raton, FL, 1990, p. 105–169.
Brawner DL, Cutler JE: OralCandida albicans isolates from non-hospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. Journal of Clinical Microbiology 1989, 27: 1335–1341.
Miyakawa Y, Kuribayashi T, Kagaya K, Suzuki M, Nakase T, Fukasawa Y: Role of specific determinants in mannan ofCandida albicans serotype A in adherence to human buccal epithelial cells. Infection and Immunity 1992, 60: 2493–2499.
Sobel JD: Genital candidiasis. In: Bodey GP (ed): Candidiasis: pathogenesis, diagnosis and treatment. Raven Press, New York, 1993, p. 225–247.
Ghannoum MA, Abu-Elteen KH: Pathogenicity determinants ofCandida. Mycoses 1990, 33: 265–282.
McCourtie J, Douglas LJ: Relationship between cell surface composition, adherence, and virulence ofCandida albicans. Infection and Immunity 1984, 45: 6–12.
Macura AB, Syslo J, Filip E: Adherence in vitro ofCandida albicans to cheek mucous membrane cells in children with immune disorders. Medycyna Doswiadczalna i Mikrobiologia 1992, 44: 69–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imbert-Bernard, C., Valentin, A., Reynes, J. et al. Relationship between fluconazole sensitivity ofCandida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count. Eur. J. Clin. Microbiol. Infect. Dis. 13, 711–716 (1994). https://doi.org/10.1007/BF02276053
Issue Date:
DOI: https://doi.org/10.1007/BF02276053